MACROGENICS INC (MGNX)
US5560991094 - Common Stock
Early Detection Breakthrough: Biotech Companies Lead the Way in Pancreatic Cancer Treatment
/PRNewswire/ -- USA News Group – A new study is bringing hope in the fight against one of the deadliest cancers, revealing a blood test that can detect...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc. - MGNX
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of MacroGenics, Inc. ("MacroGenics" or the "Company") (NASDAQ: MGNX). Such...
On Tuesday, there are stocks with unusual volume. Let's take a look.
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against MacroGenics, Inc. (MGNX)
Top movers in Monday's session
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
In today's session, these stocks are experiencing unusual volume.
Let's explore the current happenings on the US markets on Monday. Below, you'll find the stocks exhibiting unusual volume in today's session.
Here are the top movers in Monday's session, showcasing the stocks with significant price changes.
Let's take a look at the stocks that are in motion in today's session.
MacroGenics to Participate in Upcoming Investor Conferences
MacroGenics to Participate in Upcoming Investor Conferences
ROCKVILLE, MD, May 13, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and...
Notable Friday Option Activity: MGNX, MARA, IPI
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.
The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Why Is Progyny (PGNY) Stock Down 27% Today?
Progyny stock is down on Friday after the company posted a revenue miss for Q1 and disappointed PGNY investors with its guidance!
Why Is Macrogenics (MGNX) Stock Down 69% Today?
Macrogenics stock is down on Friday as MGNX investors react to clinical trial deaths and missed earnings for the first quarter of 2024.
Which stocks are moving before the opening bell on Friday?
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
The biggest pre-market stock movers are ready to go as we check out all of the hottest news happening on Friday morning!
MacroGenics (MGNX) Q1 2024 Earnings Call Transcript
MGNX earnings call for the period ending March 31, 2024.
MGNX Stock Earnings: Macrogenics Misses EPS, Misses Revenue for Q1 2024
MGNX stock results show that Macrogenics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
MGNX Stock Earnings: Macrogenics Misses EPS, Misses Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Macrogenics (NASDAQ:MGNX) just reported results for the first quarter of 2024.M...
Which stocks are moving after the closing bell on Thursday?
After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study Data
Presentation of interim TAMARACK Phase 2 study data: updated safety and preliminary efficacy of vobra duo in mCRPC patientsConference call scheduled for...
MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call
MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call
ROCKVILLE, MD, May 03, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and...
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
/PRNewswire/ -- USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed...
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
/CNW/ -- USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of...